Caribou Biosciences (CRBU) FCF Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | 43,925.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,925.00 |
| Dec 31, 2025 | 120,298.00 |
| Sep 30, 2025 | 47,242.00 |
| Jun 30, 2025 | -18,070.00 |
| Mar 31, 2025 | 99.00 |
| Dec 31, 2024 | -112,140.00 |
| Sep 30, 2024 | -151,883.00 |
| Jun 30, 2024 | -44,845.00 |
| Mar 31, 2024 | -71,991.00 |
| Dec 31, 2023 | -2,046.00 |
| Sep 30, 2023 | 69,360.00 |
| Jun 30, 2023 | 3,442.00 |
| Mar 31, 2023 | 363.00 |
| Dec 31, 2022 | 27,837.00 |
| Sep 30, 2022 | -39,852.00 |
| Jun 30, 2022 | 63,381.00 |
| Mar 31, 2022 | -212,976.00 |
| Dec 31, 2021 | -3,913.00 |
| Sep 30, 2021 | 32,690.00 |